Over One Third of Type 1 Diabetes Patients Quit Closed-Loop System – Medscape

NEW ORLEANS — Among first-time users of the MiniMed 670G hybrid closed-loop insulin delivery system (Medtronic), almost 40% stopped using the device within 9 months, primarily because of technical difficulties, shows new research presented here at ENDO 2019: The Endocrine Society Annual Meeting. Closed-loop insulin pump therapy is the most advanced technology available to date for type 1 diabetes. It’s “theoretically brilliant, and it’s the future,” said co-lead investigator Gregory Goodwin, MD, of Boston Children’s Hospital, Massachusetts, but “we need better systems,” he told a press briefing here. “For this to be available and practical for the average type 1 ...

Gepostet in der Kategorie Lebensweise (Anzahl der ansichten:) 4

Ähnlich Nachrichten